In conclusion, SPRY2 is an effective regulatory protein of the FGF/VEGF/EGF/BDNF signaling pathway and could be targeted as a therapeutic molecule in neurodevelopmental disorders. This evidence concerns the gene BDNF and neurodevelopmental disorder.